ArticleCommunications biology2026
Low initial metabolite production enhances stability in syntrophic bacterial consortia.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Low initial metabolite production enhances stability in syntrophic bacterial consortia.Communications biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Syntrophic interactions based on reciprocal metabolite exchange are widespread in microbial communities, yet the factors determining their stability remain unclear. Using synthetic Escherichia coli consortia composed of lysine and arginine auxotrophs, we show that lower initial metabolite production promotes, rather than limits, syntrophic stability. During serial propagation, replicate cocultures diverged sharply: a minority maintained sustained growth, whereas most became extinct. This divergence was associated with phenotypic differences in metabolite production among founding isolates. Consortia founded by low-producing strains recovered reliably after dilution and were more resistant to invasion by non-producing mutants. By contrast, high-producing founder generated diminishing returns for consortium growth, and increased extracellular metabolite availability that favored exploitation by non-producer. Although we detected no consistent coding-region variations between high- and low-producing isolates, expression differences suggest that outside coding regions may influence these production traits. These results identify constrained initial metabolite production as a key determinant of syntrophic stability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.